Craig Lipset

Craig Lipset designed and co-led the industry’s first fully virtual clinical trial, and continues to serve as a decentralized trials advisor to major pharmaceutical companies, as well as the Innovative Medicines Initiative in Europe. He is co-chair of the Decentralized Trials & Research Alliance, the largest non-profit collaboration advancing the global adoption of decentralized research, with more than 100 member organizations including FDA, pharma, tech, service providers, advocacy, and healthcare organizations. In his role as executive advisor, he will help MedVector develop additional revenue streams and provide marketplace insights related to MedVector‘s impact on clinical trial processes, products, and strategies.